Injectable HIV PrEP Shows 96% Infection Reduction
Lenacapavir, a new injectable HIV PrEP medication, demonstrated 96% infection reduction compared to daily Truvada in clinical trials, offering improved convenience and addressing stigma, though high cost remains a concern.
Injectable HIV PrEP Shows 96% Infection Reduction
Lenacapavir, a new injectable HIV PrEP medication, demonstrated 96% infection reduction compared to daily Truvada in clinical trials, offering improved convenience and addressing stigma, though high cost remains a concern.
Progress
48% Bias Score
HIV Treatment Access Barriers in Africa
Challenges faced in accessing HIV treatment in Africa, focusing on financial, social, and logistical barriers.
HIV Treatment Access Barriers in Africa
Challenges faced in accessing HIV treatment in Africa, focusing on financial, social, and logistical barriers.
Progress
0% Bias Score
French Court Case: Childhood Trauma and Sexual Assault
A court case in France reveals the traumatic childhood and subsequent offenses of Romain V., a man accused of multiple sexual assaults. The case underscores the devastating impact of childhood trauma and the complexities of criminal justice.
French Court Case: Childhood Trauma and Sexual Assault
A court case in France reveals the traumatic childhood and subsequent offenses of Romain V., a man accused of multiple sexual assaults. The case underscores the devastating impact of childhood trauma and the complexities of criminal justice.
Progress
0% Bias Score